Acknowledgement
본 연구는 보건복지부의 재원으로 한국보건산업진흥원의 보건의료기술연구개발사업 지원에 의하여 이루어진 것임(과제고유번호: HF20C0174).
References
- Dorsey E, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinson Dis. 2018;8(s1):S3-8. https://doi.org/10.3233/JPD-181474
- Lee JE, Choi JK, Lim HS, Kim JH, Cho JH, Kim GS. et al. The prevalence and incidence of Parkinson's disease in South Korea: a 10-year nationwide population-based study. J Korean Neurol Assoc. 2017;35(4):191-8. https://doi.org/10.17340/jkna.2017.4.1
- Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018;75(1):9-10.
- Marsden CD, Parkes JD. " On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1976;307(7954):292-6. https://doi.org/10.1016/S0140-6736(76)91416-1
- Antonini A, Martinez-Martin P, Chaudhuri RK, Merello M, Hauser R, Katzenschlager R. et al. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011;26(12):2169-75. https://doi.org/10.1002/mds.23875
- Seo JH, Cheon SM, Kim JW. The Correlation of ON and OFF Status With Clinical Characteristics in Patients With Parkinson's Disease. J Mov Disord. 2008;1(2):65-70. https://doi.org/10.14802/jmd.08012
- Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP. et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord. 2005;20(6):726-33. https://doi.org/10.1002/mds.20383
- Olanow CW, Poewe W, Rascol O, Stocchi F. On-demand therapy for OFF episodes in Parkinson's disease. Mov Disord. 2021;36(10):2244-53. https://doi.org/10.1002/mds.28726
- Factor SA, Molho ES. Emergency department presentations of patients with Parkinson's disease. Am J Emerg Med. 2000;18(2):209-15. https://doi.org/10.1016/S0735-6757(00)90023-8
- Victorino JN, Shibata Y, Inoue S, Shibata T. Understanding Wearing-Off Symptoms in Parkinson's Disease Patients using Wrist-Worn Fitness Tracker and a Smartphone. Procedia Comput Sci. 2022;196:684-91. https://doi.org/10.1016/j.procs.2021.12.064
- Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez- Martin P. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-70. https://doi.org/10.1002/mds.22340
- Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F. et al. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol. 2006;29(6):312-21. https://doi.org/10.1097/01.WNF.0000232277.68501.08
- Antonini A, Martinez-Martin P, Chaudhuri RK, Merello M, Hauser R, Katzenschlager R. et al. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011;26(12):2169-75. https://doi.org/10.1002/mds.23875
- Damasio AR, Castro-Caldas A, Levy A. The on-off effect. Adv Neurol. 1973;3:11-22.
- Sweet RD, McDowell FH. Five years' treatment of Parkinson's disease with levodopa: therapeutic results and survival of 100 patients. Ann Intern Med. 1975;83(4):456-63.
- Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K. et al. The spectrum of "off" in Parkinson's disease: what have we learned over 40 years?. Parkinsonism Relat Disord. 2018;51:9-16. https://doi.org/10.1016/j.parkreldis.2018.02.001